Format
Sort by

Send to

Choose Destination

Search results

Items: 2

1.

YES1 Is a Targetable Oncogene in Cancers Harboring YES1 Gene Amplification.

Hamanaka N, Nakanishi Y, Mizuno T, Horiguchi-Takei K, Akiyama N, Tanimura H, Hasegawa M, Satoh Y, Tachibana Y, Fujii T, Sakata K, Ogasawara K, Ebiike H, Koyano H, Sato H, Ishii N, Mio T.

Cancer Res. 2019 Aug 7. doi: 10.1158/0008-5472.CAN-18-3376. [Epub ahead of print]

PMID:
31391186
2.

Acquired JHDM1D-BRAF Fusion Confers Resistance to FGFR Inhibition in FGFR2-Amplified Gastric Cancer.

Sase H, Nakanishi Y, Aida S, Horiguchi-Takei K, Akiyama N, Fujii T, Sakata K, Mio T, Aoki M, Ishii N.

Mol Cancer Ther. 2018 Oct;17(10):2217-2225. doi: 10.1158/1535-7163.MCT-17-1022. Epub 2018 Jul 25.

Supplemental Content

Loading ...
Support Center